Related Experiment Video
Updated: May 1, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort
Matthew D Allard, Ramesh Saeedi, Masoud Yousefi
1Healthy Heart Program Prevention Clinic, St Paul's Hospital, Vancouver, University of British Columbia, Vancouver, Canada. jifr@mail.ubc.ca.
Insights
Familial hypercholesterolemia (FH) patients show varied cardiovascular disease (CVD) risk. Key factors include sex, diabetes, high cholesterol (HDL-C), and lipoprotein (a) (Lp(a)), with differing impacts between men and women.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Metabolic Disorders
Background:
- Familial hypercholesterolemia (FH) is an autosomal dominant disorder causing high cholesterol and premature cardiovascular disease (CVD).
- Significant variability exists in CVD occurrence among FH patients.
- Identifying risk factors for this variability is crucial for patient management.
Purpose of the Study:
- To determine specific risk factors contributing to the variability of cardiovascular disease (CVD) events in patients with Familial hypercholesterolemia (FH).
Main Methods:
- Retrospective analysis of a large, multiethnic cohort of definite FH patients.
- Utilized Cox proportional hazard regression to assess risk factor associations with hard cardiovascular outcomes.
Main Results:
- Identified 409 definite FH patients; 27% had CVD.
- Significant independent risk factors for CVD included male sex, family history of premature CVD, diabetes mellitus, low high-density lipoprotein cholesterol (HDL-C), and high lipoprotein (a) (Lp(a)).
- Risk factor impact differed by sex: family history and low HDL-C in men; smoking and high Lp(a) in women. Diabetes was significant for both.
Conclusions:
- Cardiovascular disease (CVD) risk factors in Familial hypercholesterolemia (FH) exhibit sex-specific influences.
- Family history and low HDL-C are key in men; smoking and high Lp(a) are key in women.
- Diabetes mellitus is a significant CVD risk factor for both sexes in FH patients.
Background:
Heterozygous Familial hypercholesterolemia (FH) is a common autosomal dominant disorder resulting in in very high blood cholesterol levels and premature cardiovascular disease (CVD). However, there is a wide variation in the occurrence of CVD in these patients. The aim of this study is to determine risk factors that are responsible for the variability of CVD events in FH patients.
Methods:
This is a retrospective analysis of a large multiethnic cohort of patients with definite FH attending the Healthy Heart Prevention Clinic in Vancouver, Canada. Cox proportional hazard regression analysis was used to assess the association of the risk factors to the hard cardiovascular outcomes.
Results:
409 patients were identified as having "definite" FH, according to the Dutch Lipid Clinic Network Criteria (DLCNC), with 111 (27%) having evidence of CVD. Male sex, family history of premature CVD, diabetes mellitus, low high density lipoprotein cholesterol (HDL-C) and high lipoprotein (a) (Lp (a)) were significant, independent risk factors for CVD. In men, family history, diabetes and low levels of HDL-C were significant risk factors while in women smoking, diabetes mellitus and high Lp (a) were significant risk factors for CVD. There were no significant differences in risk factors between ethnicities.
Conclusion:
In conclusion, men and women differ in the impact of the risk factors on the presence of CVD with family history of CVD and low HDL-C being a significant factor in men while smoking and increased Lp (a) were significant factors in women. Diabetes was a significant factor in both men and women.
Related Concept Videos
Atherosclerosis III: Management
Pharmacogenomics: Identification of New Drug Targets
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Relative Risk

